Literature DB >> 12208382

Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection.

Leslie A Lenert1, Martin Feddersen, Ann Sturley, Daniel Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12208382     DOI： 10.1016/s0002-9343(02)01156-7

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  22 in total

Review 1.  Obstacles and opportunities to improve antiretroviral regimen access in low-income countries.

Authors:  Jennifer Cohn; Brook Baker
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

2.  Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one?

Authors:  Joseph M Mrus; Kenneth E Sherman; Anthony C Leonard; Susan N Sherman; Karen L Mandell; Joel Tsevat
Journal:  Med Care       Date:  2006-02       Impact factor: 2.983

3.  Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog.

Authors:  Elijah Paintsil; Ginger E Dutschman; Rong Hu; Susan P Grill; Wing Lam; Masanori Baba; Hiromichi Tanaka; Yung-Chi Cheng
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

Review 4.  Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications.

Authors:  Jean B Nachega; Maria Paola Trotta; Mark Nelson; Adriana Ammassari
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

5.  Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study.

Authors:  Girardin Jean-Louis; Kathleen M Weber; Bradley E Aouizerat; Alexandra M Levine; Pauline M Maki; Chenglong Liu; Kathryn M Anastos; Joel Milam; Keri N Althoff; Tracey E Wilson
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

6.  The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults.

Authors:  Robert Burgoyne; Evan Collins; Cheryl Wagner; Susan Abbey; Mark Halman; Margaret Nur; Sharon Walmsley
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

7.  Upregulation of Apoptosis Pathway Genes in Peripheral Blood Mononuclear Cells of HIV-Infected Individuals with Antiretroviral Therapy-Associated Mitochondrial Toxicity.

Authors:  Yram Foli; Musie Ghebremichael; Min Li; Elijah Paintsil
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

8.  Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.

Authors:  Bruce R Schackman; Callie A Scott; Paul E Sax; Elena Losina; Timothy J Wilkin; John E McKinnon; Susan Swindells; Milton C Weinstein; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2007-09-04       Impact factor: 9.079

9.  The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study.

Authors:  Joan C Lo; Kathleen Mulligan; Mustafa A Noor; Grace A Lee; Jean-Marc Schwarz; Carl Grunfeld; Morris Schambelan
Journal:  Clin Infect Dis       Date:  2004-08-16       Impact factor: 9.079

10.  Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170.

Authors:  Daniel J Skiest; Amy Krambrink; Zhaohui Su; Kevin R Robertson; David M Margolis
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.